Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0000950170-25-032305

Chief Accounting Officer acquired 933 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Abate Kristin Chief Accounting Officer 2025-02-28 Grant or award +933 10,284 D
Derivatives
Abate Kristin Chief Accounting Officer 2025-02-28 Grant or award · Stock Option (right to buy) +1,866 1,866 D
Loading xslF345X05/ownership.xml…